Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Acknowledgement to Referees

Acknowledgement to Referees Am J Cardiovasc Drugs (2017) 17:421–423 DOI 10.1007/s40256-017-0257-9 Springer International Publishing AG, part of Springer Nature 2017 Dear Reader, As we reach the final issue of the American Journal of Cardiovascular Drugs for 2017, we wish to reflect on another successful year’s achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content. 2017 was a successful year for the American Journal of Cardiovascular Drugs: 42 articles have been published and, as of the end of September, 15 of these had been downloaded over 300 times from the journal home page on SpringerLink. The five most downloaded articles this year (downloaded over 1000 times each) have been: The Real Role of b-Blockers in Daily Cardiovascular Therapy Dezsi CA, Szentes V [https://link.springer.com/article/10.1007/s40256-017-0221-8] Clinical Pharmacology and Cardiovascular Safety of Naproxen Angiolillo DJ, Weisman SM [https://link.springer.com/article/10.1007/s40256-016-0200-5] Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners Drozd M, Jankowska EA, Banasiak W, Ponikowski P [https://link.springer.com/article/10.1007/s40256-016-0211-2] Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study ´ ˜ ´ ´ Nunez-Cortes JM, Amenos AC, Ascaso Gimilio JF, Alonso VB, Fuster http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

Acknowledgement to Referees

American Journal of Cardiovascular Drugs , Volume 17 (6) – Nov 15, 2017
Download PDF
3 pages

Loading next page...
 
/lp/springer-journals/acknowledgement-to-referees-XZmnu7PSwG

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
DOI
10.1007/s40256-017-0257-9
Publisher site
See Article on Publisher Site

Abstract

Am J Cardiovasc Drugs (2017) 17:421–423 DOI 10.1007/s40256-017-0257-9 Springer International Publishing AG, part of Springer Nature 2017 Dear Reader, As we reach the final issue of the American Journal of Cardiovascular Drugs for 2017, we wish to reflect on another successful year’s achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content. 2017 was a successful year for the American Journal of Cardiovascular Drugs: 42 articles have been published and, as of the end of September, 15 of these had been downloaded over 300 times from the journal home page on SpringerLink. The five most downloaded articles this year (downloaded over 1000 times each) have been: The Real Role of b-Blockers in Daily Cardiovascular Therapy Dezsi CA, Szentes V [https://link.springer.com/article/10.1007/s40256-017-0221-8] Clinical Pharmacology and Cardiovascular Safety of Naproxen Angiolillo DJ, Weisman SM [https://link.springer.com/article/10.1007/s40256-016-0200-5] Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners Drozd M, Jankowska EA, Banasiak W, Ponikowski P [https://link.springer.com/article/10.1007/s40256-016-0211-2] Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study ´ ˜ ´ ´ Nunez-Cortes JM, Amenos AC, Ascaso Gimilio JF, Alonso VB, Fuster

Journal

American Journal of Cardiovascular Drugs – Springer Journals

Published: Nov 15, 2017

There are no references for this article.